Previous Article | Next Article 
Infection and Immunity, September 2001, p. 5477-5486, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5477-5486.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
DNA Sequences Encoding CD4+ and CD8+
T-Cell Epitopes Are Important for Efficient Protective Immunity Induced
by DNA Vaccination with a Trypanosoma cruzi
Gene
Adriana E.
Fujimura,1
Sheila S.
Kinoshita,1
Vera L.
Pereira-Chioccola,2 and
Mauricio M.
Rodrigues1,*
Departamento de Microbiologia, Imunologia e
Parasitologia, Universidade Federal de São Paulo-Escola
Paulista de Medicina,1 and Instituto
Adolfo Lutz,2 São Paulo, Brazil
Received 10 April 2001/Accepted 4 June 2001
Immunization of BALB/c mice with a plasmid containing the gene for
Trypanosoma cruzi trans-sialidase (TS) induced antibodies that inhibited TS enzymatic activity, CD4+ Th1 and
CD8+ Tc1 cells, and protective immunity against infection.
We used this model to obtain basic information on the requirement of
CD4 or CD8 or B-cell epitopes for an effective DNA-induced immunity against T. cruzi infection. For that purpose, mice were
immunized with plasmids containing DNA sequences encoding (i) the
entire TS protein, (ii) the TS enzymatic domain, (iii) the TS
CD4+ T-cell epitopes, (iv) the TS CD8+
T-cell epitope, or (v) TS CD4+ and CD8+
T-cell epitopes. Plasmids expressing the entire TS or its enzymatic domain elicited similar levels of TS-inhibitory antibodies,
interferon (IFN-
)-producing T cells, and protective immunity against
infection. Although the plasmid expressing TS CD4 epitopes was
immunogenic, its protective efficacy against experimental infection was
limited. The plasmid expressing the CD8 epitope was poorly
immunogenic and provided little protective immunity. The reason for the
limited priming of CD8+ T cells was due to a requirement
for CD4+ T cells. To circumvent this problem, a plasmid
expressing both CD4+ and CD8+ T-cell
epitopes was produced. This plasmid generated levels of IFN-
-producing T cells and protective immunity comparable to that of
the plasmid expressing the entire catalytic domain of TS. Our
observations suggest that plasmids expressing epitopes recognized
by CD4+ and CD8+ T cells may have a better
protective potential against infection with T. cruzi.
*
Corresponding author. Mailing address: UNIFESP,
Escola Paulista de Medicina, Rua Botucatu, 862, 6° andar,
04023-062, São Paulo, SP, Brazil. Phone and fax: (55) (11)
5571-1095. E-mail: rodriguesm{at}ecb.epm.br.
Infection and Immunity, September 2001, p. 5477-5486, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5477-5486.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Silveira, E. L. V., Claser, C., Haolla, F. A. B., Zanella, L. G., Rodrigues, M. M.
(2008). Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease. CVI
15: 1292-1300
[Abstract]
[Full Text]
-
Hoft, D. F., Eickhoff, C. S., Giddings, O. K., Vasconcelos, J. R. C., Rodrigues, M. M.
(2007). Trans-Sialidase Recombinant Protein Mixed with CpG Motif-Containing Oligodeoxynucleotide Induces Protective Mucosal and Systemic Trypanosoma cruzi Immunity Involving CD8+ CTL and B Cell-Mediated Cross-Priming. J. Immunol.
179: 6889-6900
[Abstract]
[Full Text]
-
Duthie, M. S., Kahn, M., Zakayan, A., White, M., Kahn, S. J.
(2007). Parasite-Induced Chronic Inflammation Is Not Exacerbated by Immunotherapy before or during Trypanosoma cruzi Infection. CVI
14: 1005-1012
[Abstract]
[Full Text]
-
Giddings, O. K., Eickhoff, C. S., Smith, T. J., Bryant, L. A., Hoft, D. F.
(2006). Anatomical Route of Invasion and Protective Mucosal Immunity in Trypanosoma cruzi Conjunctival Infection.. Infect. Immun.
74: 5549-5560
[Abstract]
[Full Text]
-
Araujo, A. F. S., de Alencar, B. C. G., Vasconcelos, J. R. C., Hiyane, M. I., Marinho, C. R. F., Penido, M. L. O., Boscardin, S. B., Hoft, D. F., Gazzinelli, R. T., Rodrigues, M. M.
(2005). CD8+-T-Cell-Dependent Control of Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2. Infect. Immun.
73: 6017-6025
[Abstract]
[Full Text]
-
Hoft, D. F., Eickhoff, C. S.
(2005). Type 1 Immunity Provides Both Optimal Mucosal and Systemic Protection against a Mucosally Invasive, Intracellular Pathogen. Infect. Immun.
73: 4934-4940
[Abstract]
[Full Text]
-
El-Sayed, N. M., Myler, P. J., Bartholomeu, D. C., Nilsson, D., Aggarwal, G., Tran, A.-N., Ghedin, E., Worthey, E. A., Delcher, A. L., Blandin, G., Westenberger, S. J., Caler, E., Cerqueira, G. C., Branche, C., Haas, B., Anupama, A., Arner, E., Aslund, L., Attipoe, P., Bontempi, E., Bringaud, F., Burton, P., Cadag, E., Campbell, D. A., Carrington, M., Crabtree, J., Darban, H., da Silveira, J. F., de Jong, P., Edwards, K., Englund, P. T., Fazelina, G., Feldblyum, T., Ferella, M., Frasch, A. C., Gull, K., Horn, D., Hou, L., Huang, Y., Kindlund, E., Klingbeil, M., Kluge, S., Koo, H., Lacerda, D., Levin, M. J., Lorenzi, H., Louie, T., Machado, C. R., McCulloch, R., McKenna, A., Mizuno, Y., Mottram, J. C., Nelson, S., Ochaya, S., Osoegawa, K., Pai, G., Parsons, M., Pentony, M., Pettersson, U., Pop, M., Ramirez, J. L., Rinta, J., Robertson, L., Salzberg, S. L., Sanchez, D. O., Seyler, A., Sharma, R., Shetty, J., Simpson, A. J., Sisk, E., Tammi, M. T., Tarleton, R., Teixeira, S., Van Aken, S., Vogt, C., Ward, P. N., Wickstead, B., Wortman, J., White, O., Fraser, C. M., Stuart, K. D., Andersson, B.
(2005). The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease. Science
309: 409-415
[Abstract]
[Full Text]
-
Martin, D. L., Tarleton, R. L.
(2005). Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent Trypanosoma cruzi Infection. J. Immunol.
174: 1594-1601
[Abstract]
[Full Text]
-
Agusti, R., Paris, G., Ratier, L., Frasch, A. C.C., de Lederkremer, R. M.
(2004). Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo. Glycobiology
14: 659-670
[Abstract]
[Full Text]
-
Michailowsky, V., Luhrs, K., Rocha, M. O. C., Fouts, D., Gazzinelli, R. T., Manning, J. E.
(2003). Humoral and Cellular Immune Responses to Trypanosoma cruzi-Derived Paraflagellar Rod Proteins in Patients with Chagas' Disease. Infect. Immun.
71: 3165-3171
[Abstract]
[Full Text]
-
Boscardin, S. B., Kinoshita, S. S., Fujimura, A. E., Rodrigues, M. M.
(2003). Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection. Infect. Immun.
71: 2744-2757
[Abstract]
[Full Text]
-
Garg, N., Tarleton, R. L.
(2002). Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection. Infect. Immun.
70: 5547-5555
[Abstract]
[Full Text]
-
Katae, M., Miyahira, Y., Takeda, K., Matsuda, H., Yagita, H., Okumura, K., Takeuchi, T., Kamiyama, T., Ohwada, A., Fukuchi, Y., Aoki, T.
(2002). Coadministration of an Interleukin-12 Gene and a Trypanosoma cruzi Gene Improves Vaccine Efficacy. Infect. Immun.
70: 4833-4840
[Abstract]
[Full Text]
-
Schnapp, A. R., Eickhoff, C. S., Sizemore, D., Curtiss III, R., Hoft, D. F.
(2002). Cruzipain Induces Both Mucosal and Systemic Protection against Trypanosoma cruzi in Mice. Infect. Immun.
70: 5065-5074
[Abstract]
[Full Text]